Medications, which target and protect the bone from complications of metastasis, have been related with osteonecrosis of the jaw, a potentially serious lesion. The concurrent use of those medications ...[Read more]
The 2nd International Symposium on medication related osteonecrosis of the jaws in Copenhagen took place in 2 November 2018 [www.righospitalet.dk/MRONJ]. The medications which are related to MRONJ are...[Read more]
The purpose of this retrospective study was to assess patient adherence to an oral preventive measures protocol and its impact on cancer treatment outcomes. [1] The study included 133 patients, who h...[Read more]
